Dr. Matusov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8723 Alden Dr
Los Angeles, CA 90048Phone+1 310-423-8784Fax+1 310-423-2665
Education & Training
- Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2021
- Santa Barbara Cottage HospitalResidency, Internal Medicine, 2015 - 2018
Certifications & Licensure
- CA State Medical License 2017 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension Start of enrollment: 2024 Feb 01
- A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2021 Dec 02
Publications & Presentations
PubMed
- Peer Review: Insights Gleaned From Observing the Editorial Process at.Yuri Matusov, Taylor Brooks, Desiree Burroughs-Ray, Maniraj Neupane
Annals of Internal Medicine. 2024-11-19 - 1 citationsEffect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.Tomas O Jensen, Greg A Grandits, Mamta K Jain, Thomas A Murray, Birgit Grund
The Journal of Infectious Diseases. 2024-03-14 - The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.Michael I Lewis, Shelley Shapiro, Ronald J Oudiz, Mamoo Nakamura, Dael Geft
Ebiomedicine. 2024-02-01
Professional Memberships
- Member
- Member
- Member
- Pulmonary Hypertension AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: